94 related articles for article (PubMed ID: 2016905)
1. Etoposide inhibition of methylaminoisobutyric acid transport and its recovery in K562 cells.
Shionoya S
Leuk Res; 1991; 15(2-3):137-41. PubMed ID: 2016905
[TBL] [Abstract][Full Text] [Related]
2. IL-2 inhibits proliferation of K562 cells and reduces accumulation of bcr/abl mRNA and oncoprotein.
Dilloo D; Hanenberg H; Lion T; Burdach S
Leukemia; 1995 Mar; 9(3):419-24. PubMed ID: 7885040
[TBL] [Abstract][Full Text] [Related]
3. Enhancement of etoposide and methotrexate sensitivity by indomethacin in vitro.
Maca RD
Anticancer Drug Des; 1991 Nov; 6(5):453-66. PubMed ID: 1722410
[TBL] [Abstract][Full Text] [Related]
4. Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.
Ritke MK; Roberts D; Allan WP; Raymond J; Bergoltz VV; Yalowich JC
Br J Cancer; 1994 Apr; 69(4):687-97. PubMed ID: 8142256
[TBL] [Abstract][Full Text] [Related]
5. [Retinoic acid intensifies the suppression of the proliferation of K562 cells by phorbol ester].
Chistokhina AV; Medvedev AV
Tsitologiia; 1993; 35(8):52-8. PubMed ID: 8266575
[TBL] [Abstract][Full Text] [Related]
6. Combination toxicity of etoposide (VP-16) and photosensitisation with a water-soluble aluminium phthalocyanine in K562 human leukaemic cells.
Gantchev TG; Brasseur N; van Lier JE
Br J Cancer; 1996 Nov; 74(10):1570-7. PubMed ID: 8932337
[TBL] [Abstract][Full Text] [Related]
7. The importance of drug scheduling and recovery phases in determining drug activity. Improving etoposide efficacy in BCR-ABL-positive CML cells.
Liu WM; Lawrence AJ; Joel SP
Eur J Cancer; 2002 Apr; 38(6):842-50. PubMed ID: 11937320
[TBL] [Abstract][Full Text] [Related]
8. System A amino acid transport in cultured human tumor cells: implications for tumor imaging with PET.
Bading JR; Kan-Mitchell J; Conti PS
Nucl Med Biol; 1996 Aug; 23(6):779-86. PubMed ID: 8940721
[TBL] [Abstract][Full Text] [Related]
9. Amino acid transport by the cultured human placental trophoblast: effect of insulin on AIB transport.
Karl PI; Alpy KL; Fisher SE
Am J Physiol; 1992 Apr; 262(4 Pt 1):C834-9. PubMed ID: 1566812
[TBL] [Abstract][Full Text] [Related]
10. Antisense BCR-ABL oligomers cause non-specific inhibition of chronic myeloid leukemia cell lines.
O'Brien SG; Kirkland MA; Melo JV; Rao MH; Davidson RJ; McDonald C; Goldman JM
Leukemia; 1994 Dec; 8(12):2156-62. PubMed ID: 7808004
[TBL] [Abstract][Full Text] [Related]
11. Non-ionic detergent Tween 80 modulates VP-16 resistance in classical multidrug resistant K562 cells via enhancement of VP-16 influx.
Yamazaki T; Sato Y; Hanai M; Mochimaru J; Tsujino I; Sawada U; Horie T
Cancer Lett; 2000 Feb; 149(1-2):153-61. PubMed ID: 10737719
[TBL] [Abstract][Full Text] [Related]
12. Modulation of etoposide (VP-16) cytotoxicity by verapamil or cyclosporine in multidrug-resistant human leukemic cell lines and normal bone marrow.
Chao NJ; Aihara M; Blume KG; Sikic BI
Exp Hematol; 1990 Dec; 18(11):1193-8. PubMed ID: 2226679
[TBL] [Abstract][Full Text] [Related]
13. Characterization of methylaminoisobutyric acid transport by system A in rat mammary gland.
Tovar AR; Avila E; DeSantiago S; Torres N
Metabolism; 2000 Jul; 49(7):873-9. PubMed ID: 10909998
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of chronic myelogenous leukemia cells harboring a BCR-ABL B3A2 junction by antisense oligonucleotides targeted at the B2A2 junction.
Mahon FX; Ripoche J; Pigeonnier V; Jazwiec B; Pigneux A; Moreau JF; Reiffers J
Exp Hematol; 1995 Dec; 23(14):1606-11. PubMed ID: 8542954
[TBL] [Abstract][Full Text] [Related]
15. Insulin-stimulated alpha-(methyl)aminoisobutyric acid uptake in skeletal muscle. Evidence for a short-term activation of uptake independent of Na+ electrochemical gradient and protein synthesis.
Gumà A; Testar X; Palacín M; Zorzano A
Biochem J; 1988 Aug; 253(3):625-9. PubMed ID: 2460082
[TBL] [Abstract][Full Text] [Related]
16. [p21(WAF1) transfection decreases sensitivity of K562 cells to VP-16].
Yang H; Wang SW; Yin HJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):31-4. PubMed ID: 12513833
[TBL] [Abstract][Full Text] [Related]
17. Selective inhibition of leukemia cell proliferation by BCR-ABL antisense oligodeoxynucleotides.
Szczylik C; Skorski T; Nicolaides NC; Manzella L; Malaguarnera L; Venturelli D; Gewirtz AM; Calabretta B
Science; 1991 Aug; 253(5019):562-5. PubMed ID: 1857987
[TBL] [Abstract][Full Text] [Related]
18. Divalproex sodium enhances the anti-leukemic effects of imatinib in chronic myeloid leukemia cells partly through SIRT1.
Wang W; Zhang J; Li Y; Yang X; He Y; Li T; Ren F; Zhang J; Lin R
Cancer Lett; 2015 Jan; 356(2 Pt B):791-9. PubMed ID: 25449787
[TBL] [Abstract][Full Text] [Related]
19. Reversal of the resistance to STI571 in human chronic myelogenous leukemia K562 cells.
Mukai M; Che XF; Furukawa T; Sumizawa T; Aoki S; Ren XQ; Haraguchi M; Sugimoto Y; Kobayashi M; Takamatsu H; Akiyama S
Cancer Sci; 2003 Jun; 94(6):557-63. PubMed ID: 12824882
[TBL] [Abstract][Full Text] [Related]
20. Differential induction of etoposide-mediated apoptosis in human leukemia HL-60 and K562 cells.
Ritke MK; Rusnak JM; Lazo JS; Allan WP; Dive C; Heer S; Yalowich JC
Mol Pharmacol; 1994 Oct; 46(4):605-11. PubMed ID: 7969039
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
